Kahveci, A.M. and Tahan, V. 2016. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies. Turkish Journal of Gastroenterology. 27, 1 (Jan. 2016), 89–90. DOI:https://doi.org/10.5152/tjg.2015.150012.